Related references
Note: Only part of the references are listed.Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1
Ewelina Mamcarz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
CRISPR-Cas9: A cornerstone for the evolution of precision medicine
Sleiman Razzouk
ANNALS OF HUMAN GENETICS (2018)
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
Ema Robinson et al.
MOLECULAR THERAPY (2018)
A highly specific SpCas9 variant is identified by in vivo screening in yeast
Antonio Casini et al.
NATURE BIOTECHNOLOGY (2018)
Cas9 versus Cas12a/Cpf1: Structure-function comparisons and implications for genome editing
Daan C. Swarts et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2018)
VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9
Claudia Montagna et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
CRISPR-Cas guides the future of genetic engineering
Gavin J. Knott et al.
SCIENCE (2018)
Predictable and precise template-free CRISPR editing of pathogenic variants
Max W. Shen et al.
NATURE (2018)
In vitro Methods for the Development and Analysis of Human Primary Airway Epithelia
Ambra Gianotti et al.
FRONTIERS IN PHARMACOLOGY (2018)
Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine
Nikhil T. Awatade et al.
FRONTIERS IN PHARMACOLOGY (2018)
Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway Epithelia
Elvira Sondo et al.
CELL CHEMICAL BIOLOGY (2018)
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
Eric W. F. W. Alton et al.
THORAX (2017)
Genetic Modification of the Lung Directed Toward Treatment of Human Disease
Dolan Sondhi et al.
HUMAN GENE THERAPY (2017)
CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10
Guo-Xiang Ruan et al.
MOLECULAR THERAPY (2017)
Engineered Cpf1 variants with altered PAM specificities
Linyi Gao et al.
NATURE BIOTECHNOLOGY (2017)
Roadmap for an early gene therapy for cystic fibrosis airway disease
Marianne S. Carlon et al.
PRENATAL DIAGNOSIS (2017)
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit
Gianluca Petris et al.
NATURE COMMUNICATIONS (2017)
Inherited determinants of early recurrent somatic mutations in prostate cancer
Alessandro Romanel et al.
NATURE COMMUNICATIONS (2017)
rAAV-CFTRAR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice
Dragana Vidovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks
Megan van Overbeek et al.
MOLECULAR CELL (2016)
An essential receptor for adeno-associated virus infection
S. Pillay et al.
NATURE (2016)
Analyzing CRISPR genome-editing experiments with CRISPResso
Luca Pinello et al.
NATURE BIOTECHNOLOGY (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells
Benjamin P. Kleinstiver et al.
NATURE BIOTECHNOLOGY (2016)
Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells
Daesik Kim et al.
NATURE BIOTECHNOLOGY (2016)
Organoids as an in vitro model of human development and disease
Aliya Fatehullah et al.
NATURE CELL BIOLOGY (2016)
Genetic medicines for CF: Hype versus reality
Eric W. F. W. Alton et al.
PEDIATRIC PULMONOLOGY (2016)
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
Johanna F. Dekkers et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model
Christien Bednarski et al.
PLOS ONE (2016)
Engineered tobacco etch virus (TEV) protease active in the secretory pathway of mammalian cells
Francesca Cesaratto et al.
JOURNAL OF BIOTECHNOLOGY (2015)
Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium
Nicole Ali McNeer et al.
NATURE COMMUNICATIONS (2015)
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
Eric W. F. W. Alton et al.
LANCET RESPIRATORY MEDICINE (2015)
Reduction of HIV-1 Infectivity through Endoplasmic Reticulum-Associated Degradation-Mediated Env Depletion
Antonio Casini et al.
JOURNAL OF VIROLOGY (2015)
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Shengdar Q. Tsai et al.
NATURE BIOTECHNOLOGY (2015)
Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases
Richard L. Frock et al.
NATURE BIOTECHNOLOGY (2015)
Cystic fibrosis genetics: from molecular understanding to clinical application
Garry R. Cutting
NATURE REVIEWS GENETICS (2015)
Immunological Ignorance Allows Long-Term Gene Expression After Perinatal Recombinant Adeno-Associated Virus-Mediated Gene Transfer to Murine Airways
Marianne S. Carlon et al.
HUMAN GENE THERAPY (2014)
Targeted genome editing in human repopulating haematopoietic stem cells
Pietro Genovese et al.
NATURE (2014)
Easy quantitative assessment of genome editing by sequence trace decomposition
Eva K. Brinkman et al.
NUCLEIC ACIDS RESEARCH (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients
Gerald Schwank et al.
CELL STEM CELL (2013)
A functional CFTR assay using primary cystic fibrosis intestinal organoids
Johanna F. Dekkers et al.
NATURE MEDICINE (2013)
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects
Eugenio Fernandez Alanis et al.
HUMAN MOLECULAR GENETICS (2012)
Virus-mediated gene delivery for human gene therapy
Mauro Giacca et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Extensive Methylation of Promoter Sequences Silences Lentiviral Transgene Expression During Stem Cell Differentiation In Vivo
Friederike Herbst et al.
MOLECULAR THERAPY (2012)
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Toshiro Sato et al.
GASTROENTEROLOGY (2011)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing
Tsuyoshi Kashima et al.
HUMAN MOLECULAR GENETICS (2007)
Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: A Randomized placebo-controlled phase 2B trial
Richard B. Moss et al.
HUMAN GENE THERAPY (2007)
SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer
Ernanuele Buratti et al.
NUCLEIC ACIDS RESEARCH (2007)
Use of minigene systems to dissect alternative splicing elements
TA Cooper
METHODS (2005)
The CFTR 3849+10kbC->T and 2789+5G->A alleles are a ssociated with a mild CF phenotype
I Duguépéroux et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals
G Yeo et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2004)
5′ Exon replacement and repair by spliceosome-mediated RNA trans-splicing
SG Mansfield et al.
RNA (2003)
Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes:: a large European study
MD Amaral et al.
JOURNAL OF MEDICAL GENETICS (2001)
Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1α promoter
DR Gill et al.
GENE THERAPY (2001)
Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations
M Nissim-Rafinia et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
